Professor Angus Dalgleish
Consultant Medical Oncologist
QualificationsMD FRCP FRACP FRCPath Fmed Sci
Cancer immunotherapy. Especially as applied to melanoma, prostate, pancreatic, gliomas and other solid tumour types.
Fees, Training & Background:
Professor Angus Dalgleish studied medicine at University College London where he obtained an MBBS and a BSc in Anatomy. He is a Fellow of The Royal College of Physicians of the UK and Australia, Royal College of Pathologists and The Academy of Medical Scientists. After graduating and house jobs in London and Poole he spent a year in the flying doctor service in Queensland. He also trained in Internal Medicine and Oncology in Brisbane and Sydney.
Following an interest in how viruses caused cancer, he commenced an MD with Professor Robin Weiss, FRS at the Institute of Cancer Research and Royal Marsden Hospital. Following five years as a clinical scientist at the MRC’s clinical research centre in Northwick Park, he was appointed to the Foundation Chair in Oncology at St. George’s University of London in 1991. There his main interest has been the immunology of cancer and the development of immunotherapies to treat, in particular, melanoma.
He is a co-founder of Onyvax, a company set up in 1998 to make novel vaccines for common solid tumours, where he is currently Research Director.
He currently sits on eight editorial boards, is the author or co-author of peer reviewed scientific papers and over 70 chapters in medical books. He is the co-editor of five medical books. He has been on numerous grant committees and is currently on the European Commission Cancer Board.
Clinic Times: By appointment only